Timeline How the Center for Biodefense and Emerging Infectious Diseases Evolved
NIH/NIAID awards the Fogarty International Center training program grant on the impact of zoonotic and vector-borne viruses, rickettsiae, and Leptospira in acute undifferentiated febrile illnesses.
NIH/NIAID awards the Center of Excellence for Translational Research U19 grant "Advancement of Treatments for Ebola and Marburg Virus Infections"
Dr. Peter Melby joins UTMB and heads Center for Tropical Diseases.
NIH/NIAID the Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (WRCE) grant renewed.
Galveston National Laboratory opens.
The Robert E. Shope, MD, Laboratory in the John Sealy Pavilion for Infectious Diseases Research commissioned; Institute for Human Infections and Immunity (IHII) established
WRCE and GNL awards made; Center for Biodefense and Emerging Infectious Diseases established; The Robert E. Shope, MD Laboratory dedicated
NIAID Hepatitis Antiviral contract & NIAID Emerging Infectious Disease Research contract awarded; BSL4 lab ground-breaking
UTMB Center for Biodefense established; Sept. 11 and anthrax attacks occur
WHO Collaborating Center for Arbovirus and Hemorrhagic Fever Reference and Research established; DARPA biodefense grant awarded; UTMB President Dr. Jack Stobo endorses concept of constructing BSL4 lab on campus
Strategy for developing BSL4 lab proposed by Dr. David Walker
WHO Collaborating Center for Tropical Diseases established; Drs. Robert Tesh and Robert Shope relocate from Yale University; World Reference Center for Arboviruses established
Center for Tropical Diseases established
Concept of Center for Tropical Diseases proposed